Getting to First Patient In is One Thing.
Getting to Last Patient In is Everything.
Allucent’s Integrated Global Network for Innovative Trial Execution (IGNITE™) is a global network of prequalified clinical research sites and site networks therapeutically aligned to the Allucent Centers of Expertise (ACE). IGNITE has been specifically designed to increase study predictability including study start-up, patient enrollment and overall study execution.
Built on long term strategic partnerships rather than tactical site selection, the IGNITE network brings together consistently high-performing research sites to accelerate study start-up and streamline site activation, with a focus on achieving both rapid FPI and sustained enrollment performance through LPI.
The network provides access to specialist investigators committed to responsiveness, protocol adherence, predictable enrollment, low patient drop-out rates, and the delivery of high data quality you can trust.
Accelerate study start-up with IGNITE through access to pre-qualified sites committed to defined timelines, including rapid feasibility response, and site activation within 60 days of final protocol.
Improve enrollment confidence through accurate feasibility, high-performing sites, specialist patient access, and recruitment strategies that support predictable enrollment from the first to the last patient in.
Reduce execution variability through technology and AI-enabled processes and standardized workflows, to ensure consistency and scalable performance across geographies.
Generate reliable clinical data through rigorous protocol execution, proactive data surveillance, and consistent quality standards from first patient through database lock.
The IGNITE clinical trial site network provides sponsors with access to specialist investigators and research sites with deep expertise across oncology and hematology, neuroscience, cardiometabolic disease, immunology and inflammation, infectious diseases, rare diseases, and cell and gene therapies.
These sites are selected not only for their operational performance, but also for their experience managing complex patient populations and delivering studies in challenging therapeutic areas.
Through established patient relationships and a strong understanding of disease-specific treatment pathways, IGNITE investigators bring a practical understanding of the patient journey and evolving standards of care, helping navigate the operational complexities of clinical trial delivery.
The IGNITE site network combines global reach with local precision to support clinical trials across North America, Europe, Africa and Asia-Pacific. Through deep regional expertise, established site partnerships, and scalable infrastructure, IGNITE delivers consistent operational execution across diverse regulatory and healthcare environments.
Access to underserved populations, region-specific patient pools, and emerging markets helps sponsors identify eligible patients faster and address recruitment challenges. From accelerating Phase I studies in Australia to leveraging established patient access pathways across Eastern Europe, IGNITE delivers optimal country and site selection while maintaining high standards for data quality and study oversight.
“The strength of any clinical trial starts with the strength of its sites and the patients they serve. IGNITE brings together trusted partnerships, operational consistency, and therapeutic expertise to connect the right patients to the right studies, helping sponsors achieve their development goals faster.”
A clinical site network is a group of prequalified clinical research sites that work under a standardized framework to support clinical trials. By partnering with experienced investigators and research centers, sponsors can accelerate site activation, improve study execution, and achieve more predictable patient enrollment across global trials.
Successful studies require investigators who understand the nuances of the specific indication being studied. Aligning site selection to therapeutic and indication-specific expertise gives sponsors access to clinical research sites and investigators with deep knowledge of the disease, patient population, treatment landscape, and standards of care most relevant to their study.
A global clinical site network provides access to experienced investigators, standardized site processes, and geographically diverse research sites. This can improve feasibility, accelerate site activation, enhance patient enrollment, and reduce the operational risks associated with global clinical trials.
The IGNITE Site Network supports all phases of clinical development, from first-in-human Phase I studies to Phase IV observational research, with access to more than 300 beds globally for healthy volunteer and patient studies.
The IGNITE Site Network is aligned with Allucent's Centers of Expertise and supports a range of therapeutic areas including oncology and hematology, neuroscience, cardiometabolic diseases, immunology and inflammation, infectious diseases, and rare diseases. This specialized approach helps identify the right sites and investigators for complex clinical trials.
